C. Orr
发表
Dolores Diaz,
Jianping Yin,
Michael Burkard,
2016,
Journal of medicinal chemistry.
M. Belvin,
K. Hoeflich,
J. Chan,
2010,
Xenobiotica; the fate of foreign compounds in biological systems.
W. Hopman,
R. Ramjeesingh,
C. Orr,
2016,
Current oncology.
R. Houlden,
W. Hopman,
C. Orr,
2015,
Diabetes technology & therapeutics.
Salem,
P. Ellis,
J. Leverson,
2020
.
M. Belvin,
K. Hoeflich,
H. Koeppen,
2009
.
David P. Davis,
K. Hoeflich,
L. Friedman,
2008,
The Journal of cell biology.
Ariana Peck,
Shiuh-Ming Luoh,
Steve Price,
2013,
Nature.
Dhara N. Amin,
R. Neve,
Ivana Yen,
2018,
Cancer cell.
William Pao,
Thomas Zander,
Martin Peifer,
2009,
Proceedings of the National Academy of Sciences.
Saroja Ramanujan,
Kapil Gadkar,
Daniel C. Kirouac,
2017,
npj Systems Biology and Applications.
P. Hegde,
Z. Modrušan,
James Ziai,
2022,
Cell reports. Medicine.
Mark Merchant,
M. Belvin,
I. Kasman,
2012,
Cancer research.
Jack R. Davis,
Z. Cao,
K. Bass,
2006,
Molecular Cancer Therapeutics.
C. Eigenbrot,
Ivana Yen,
S. Malek,
2021,
Journal of medicinal chemistry.
W. Hopman,
R. Ramjeesingh,
C. Orr,
2016,
Current oncology.
P. Ellis,
J. Leverson,
T. Uziel,
2020,
Cancer Discovery.
M. Belvin,
K. Hoeflich,
M. Merchant,
2012,
Drug Metabolism and Disposition.
K. Gadkar,
D. Kirouac,
S. Ramanujan,
2017,
npj Systems Biology and Applications.
Combined MEK and ERK inhibition overcomes therapy-mediated pathway reactivation in RAS mutant tumors
Lily Shao,
Mark Merchant,
Eva Lin,
2017,
PloS one.
M. Belvin,
D. Kirouac,
H. Koeppen,
2018,
PloS one.
M. Belvin,
K. Hoeflich,
H. Koeppen,
2010
.
S. Gould,
M. Belvin,
Peter Yin,
2014
.
C. Eigenbrot,
Ivana Yen,
S. Malek,
2021,
ACS medicinal chemistry letters.
K. Gadkar,
D. Kirouac,
S. Ramanujan,
2016
.
J. Grandner,
Steffan Vartanian,
John G. Moffat,
2023,
ACS medicinal chemistry letters.